<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian journal of Pediatric Hematology and Oncology</title>
<title_fa>Iranian journal of Pediatric Hematology and Oncology</title_fa>
<short_title>Iran J Ped Hematol Oncol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijpho.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-8892</journal_id_issn>
<journal_id_issn_online>2228-6993</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The correlation between zinc and monocyte phagocytosis in patients with major b-thalassemia</title>
	<subject_fa>قلب</subject_fa>
	<subject>Heart</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div&gt;&lt;strong&gt;Background: &lt;/strong&gt;Zinc depletion decreases monocyte functions and survival while excessive amount of zinc inhibits monocyte activation. Monocytes shift from conducting intercellular communication to becoming innate immune function as a response. This study aims to examine the influence of zinc status on the monocyte phagocytosis in patients with major beta-thalassemia.&lt;br&gt;
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;This study was a randomized-placebo-controlled trial. The patients were randomly assigned into either the zinc-treated group using zinc gluconate 50mg daily or the placebo group. Analysis is based on the 12-weeks observation of the complete blood count, plasma zinc level, and phagocytosis level of monocytes. The phagocytic activity of monocytes was measured using atomic absorption spectroscopy (AAS) or x-ray fluorescence (XRF). The comparisons of the data within each group were analyzed using Mann-Whitney test.&lt;br&gt;
&lt;strong&gt;Results: &lt;/strong&gt;The results indicated no significant differences in patients&amp;rsquo; characteristics; the level of plasma zinc at week 12 in the zinc-treated group (67.41+14.4) was significantly higher than the placebo group (54.37+9.38) (p=0.047). The phagocytosis levels of monocyte at week 12 in zinc-treated group (8.70+4.61) were higher than the placebo groups (8.23+4.22) (p=0.002). The ferritin level of zinc-treated group was higher than placebo group (p=0.084), while high level of ferritin is associated with higher level of monocyte phagocytic activity, the result is statistically significant (p=0.002). The results also showed that higher level of plasma zinc insignificantly correlates with lower phagocytic activity of the monocytes (p=0.059).&lt;br&gt;
&lt;strong&gt;Conclusion: &lt;/strong&gt;The immune mechanisms in response to zinc-deficient environment underlying the shifting between adaptive to innate immune response involves multiple molecular components of the immune system and have been attributed to specific features of -thalassemia, in which overall immune activity is decreased even though the phagocytic activity of monocytes is increased.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Major beta thalassemia, Monocytes, Phagocytosis, Zinc</keyword>
	<start_page>24</start_page>
	<end_page>29</end_page>
	<web_url>http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-636-3&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Teny </first_name>
	<middle_name></middle_name>
	<last_name>Tjitra Sari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Hematology-oncology Division, Department of Pediatrics, Cipto Mangunkusumo General Hospital – Faculty of Medicine, University of Indonesia, Jakarta,  Indonesia </affiliation>
	<affiliation_fa>Hematology-oncology Division, Department of Pediatrics, Cipto Mangunkusumo General Hospital – Faculty of Medicine, University of Indonesia, Jakarta,  Indonesia</affiliation_fa>
	 </author>


	<author>
	<first_name>Dewi </first_name>
	<middle_name></middle_name>
	<last_name>Wulandari </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0002-3656-7813</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Pathology, Faculty of MeMedicine, University of Indonesia, Jakarta, Indonesia</affiliation>
	<affiliation_fa>Department of Clinical Pathology, Faculty of MeMedicine, University of Indonesia, Jakarta, Indonesia</affiliation_fa>
	 </author>


	<author>
	<first_name>Astrid Indrafebrina </first_name>
	<middle_name></middle_name>
	<last_name>Sugianto </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>University of Indonesia, Jakarta, Indonesia</affiliation>
	<affiliation_fa>University of Indonesia, Jakarta, Indonesia</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
